<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Matinas Biopharma Holdings, Inc. — News on 6ix</title>
    <link>https://6ix.com/company/matinas-biopharma-holdings-inc</link>
    <description>Latest news and press releases for Matinas Biopharma Holdings, Inc. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 03 Apr 2026 21:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/matinas-biopharma-holdings-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d76e0f51cc36e47533d198.webp</url>
      <title>Matinas Biopharma Holdings, Inc.</title>
      <link>https://6ix.com/company/matinas-biopharma-holdings-inc</link>
    </image>
    <item>
      <title>Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards</title>
      <link>https://6ix.com/company/matinas-biopharma-holdings-inc/news/matinas-biopharma-receives-notice-of-non-compliance-with-nyse-american-continued-listing-standards</link>
      <guid isPermaLink="true">https://6ix.com/company/matinas-biopharma-holdings-inc/news/matinas-biopharma-receives-notice-of-non-compliance-with-nyse-american-continued-listing-standards</guid>
      <pubDate>Fri, 03 Apr 2026 21:00:00 GMT</pubDate>
      <description>BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on April 2, 2026, it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $2.0</description>
    </item>
  </channel>
</rss>